University of Cambridge

Chemistry of Health

UKRPIF award: £17.6 million
Officially opened: September 2018

The Chemistry of Health building is a state-of-the-art facility designed to support research into neurodegenerative disorders such as Parkinson’s and Alzheimer’s diseases.

The 2,600m2 building includes:

  • Business incubation space, including laboratory and desk space, for industrial partners and start-ups to work alongside academic researchers
  • The Centre for Protein Misfolding Disease, dedicated to the study of misfolding proteins in human cells, which causes a range of disorders
  • The Molecular Production and Characterisation Centre, which will provide support and access to state-of-the-art instrumentation for in-house, UK-wide academic and industrial users in chemistry.

The UK Research Partnership Investment Fund (UKRPIF) award supported construction of the centre, which secured co-investment from leading pharma companies including Elan Pharmaceuticals, AstraZeneca and Pfizer, as well as philanthropic donations.